Aspen Grove Capital, LLC Takeda Pharmaceutical CO LTD Transaction History

Aspen Grove Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$12.6 - $13.67 $630 - $683	-50 Reduced 0.49%	10,146 $134 Million
Q1 2024 May 15, 2024	BUY	$13.89 - $15.04 $1,194 - $1,293	86 Added 0.85%	10,196 $142 Million
Q4 2023 Feb 14, 2024	BUY	$13.36 - $15.43 $135,069 - $155,997	10,110 New	10,110 $144 Million
Q2 2023 Aug 14, 2023	SELL	$15.57 - $17.11 $14,324 - $15,741	-920 Reduced 8.19%	10,310 $165 Million
Q1 2023 May 15, 2023	BUY	$15.28 - $16.48 $16,471 - $17,765	1,078 Added 10.62%	11,230 $185 Million
Q4 2022 Feb 14, 2023	BUY	$12.42 - $15.62 $126,087 - $158,574	10,152 New	10,152 $158 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Aspen Grove Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Aspen Grove Capital, LLC with notifications on news.